RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-15.48%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$504M
AUM Growth
+$504M
(-24%)
Cap. Flow
-$64.4M
Cap. Flow
% of AUM
-12.78%
Top 10 Holdings %
Top 10 Hldgs %
27.49%
Holding
102
New
6
Increased
45
Reduced
33
Closed
10
Top Buys
| 1 |
Biogen
BIIB
|
$9.89M |
| 2 |
Alkermes
ALKS
|
$8.44M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$5.94M |
| 4 |
Gilead Sciences
GILD
|
$5.14M |
| 5 |
Incyte
INCY
|
$4.35M |
Top Sells
| 1 |
Perrigo
PRGO
|
$10.7M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$9.01M |
| 3 |
Medtronic
MDT
|
$8.4M |
| 4 |
HNT
HEALTH NET INC
HNT
|
$8.35M |
| 5 |
UnitedHealth
UNH
|
$7.86M |
Sector Composition
| 1 | Healthcare | 93.13% |
| 2 | Financials | 1.49% |